GNA12 and IL3RA |
guanine nucleotide binding protein (G protein) alpha 12 |
interleukin 3 receptor, alpha (low affinity) |
- Thrombin signalling through proteinase activated receptors (PARs)
- Signaling by GPCR
- GPCR downstream signaling
- G alpha (12/13) signalling events
- Platelet activation, signaling and aggregation
|
- Signaling by GPCR
- G-protein beta:gamma signalling
- Cytokine Signaling in Immune system
- GPCR downstream signaling
- Signaling by Interleukins
- Interleukin receptor SHC signaling
- G beta:gamma signalling through PI3Kgamma
- Interleukin receptor SHC signaling
- GPVI-mediated activation cascade
- Interleukin-2 signaling
- Platelet activation, signaling and aggregation
- Interleukin-3, 5 and GM-CSF signaling
|
|
|
|
|
GNAI1 and GPR1 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
G protein-coupled receptor 1 |
- Signaling by GPCR
- Integration of energy metabolism
- G alpha (s) signalling events
- Activation of GABAB receptors
- Signal amplification
- G alpha (z) signalling events
- G alpha (i) signalling events
- Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
- ADP signalling through P2Y purinoceptor 12
- GABA B receptor activation
- Adenylate cyclase inhibitory pathway
- GABA receptor activation
- PLC beta mediated events
- Opioid Signalling
- Regulation of insulin secretion
- G-protein mediated events
- Adrenaline,noradrenaline inhibits insulin secretion
- Inhibition of adenylate cyclase pathway
- Adenylate cyclase inhibitory pathway
- GPCR downstream signaling
- G-protein activation
- Platelet activation, signaling and aggregation
- Transmission across Chemical Synapses
|
|
|
|
|
|
GNAI1 and PTPRU |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
protein tyrosine phosphatase, receptor type, U |
- Signaling by GPCR
- Integration of energy metabolism
- G alpha (s) signalling events
- Activation of GABAB receptors
- Signal amplification
- G alpha (z) signalling events
- G alpha (i) signalling events
- Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
- ADP signalling through P2Y purinoceptor 12
- GABA B receptor activation
- Adenylate cyclase inhibitory pathway
- GABA receptor activation
- PLC beta mediated events
- Opioid Signalling
- Regulation of insulin secretion
- G-protein mediated events
- Adrenaline,noradrenaline inhibits insulin secretion
- Inhibition of adenylate cyclase pathway
- Adenylate cyclase inhibitory pathway
- GPCR downstream signaling
- G-protein activation
- Platelet activation, signaling and aggregation
- Transmission across Chemical Synapses
|
|
|
|
|
|
GNAI2 and PTPRU |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
protein tyrosine phosphatase, receptor type, U |
- Signaling by GPCR
- Integration of energy metabolism
- G alpha (s) signalling events
- Activation of GABAB receptors
- Signal amplification
- G alpha (z) signalling events
- G alpha (i) signalling events
- Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
- ADP signalling through P2Y purinoceptor 12
- GABA B receptor activation
- Adenylate cyclase inhibitory pathway
- GABA receptor activation
- PLC beta mediated events
- Opioid Signalling
- Regulation of insulin secretion
- G-protein mediated events
- Adrenaline,noradrenaline inhibits insulin secretion
- Inhibition of adenylate cyclase pathway
- Adenylate cyclase inhibitory pathway
- GPCR downstream signaling
- G-protein activation
- Platelet activation, signaling and aggregation
- Transmission across Chemical Synapses
|
|
|
|
|
|
GNAI3 and PTPRU |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 |
protein tyrosine phosphatase, receptor type, U |
- GABA B receptor activation
- GABA receptor activation
- Adenylate cyclase inhibitory pathway
- Signaling by GPCR
- PLC beta mediated events
- Activation of GABAB receptors
- G alpha (s) signalling events
- Opioid Signalling
- Signal amplification
- G-protein mediated events
- Inhibition of adenylate cyclase pathway
- Adenylate cyclase inhibitory pathway
- GPCR downstream signaling
- G-protein activation
- G alpha (z) signalling events
- G alpha (i) signalling events
- Platelet activation, signaling and aggregation
- Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
- ADP signalling through P2Y purinoceptor 12
- Transmission across Chemical Synapses
|
|
|
|
|
|
GNAO1 and PTPRU |
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O |
protein tyrosine phosphatase, receptor type, U |
- Signaling by GPCR
- Ca2+ pathway
- PLC beta mediated events
- G-protein activation
- Opioid Signalling
- Signaling by Wnt
- G-protein mediated events
- beta-catenin independent WNT signaling
|
|
|
|
|
|
GNB1 and DISC1 |
guanine nucleotide binding protein (G protein), beta polypeptide 1 |
disrupted in schizophrenia 1 |
- Signaling by GPCR
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- ADP signalling through P2Y purinoceptor 1
- Integration of energy metabolism
- G alpha (s) signalling events
- Activation of GABAB receptors
- Glucagon-type ligand receptors
- G beta:gamma signalling through PLC beta
- Signaling by Wnt
- Metabolic disorders of biological oxidation enzymes
- G protein gated Potassium channels
- Olfactory Signaling Pathway
- Gastrin-CREB signalling pathway via PKC and MAPK
- Thromboxane signalling through TP receptor
- G alpha (z) signalling events
- G alpha (i) signalling events
- Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
- ADP signalling through P2Y purinoceptor 12
- Glucagon signaling in metabolic regulation
- Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits
- Inwardly rectifying K+ channels
- G-protein beta:gamma signalling
- Opioid Signalling
- Activation of Kainate Receptors upon glutamate binding
- Diseases associated with visual transduction
- Aquaporin-mediated transport
- Adrenaline,noradrenaline inhibits insulin secretion
- G alpha (q) signalling events
- GPCR downstream signaling
- Platelet homeostasis
- Platelet activation, signaling and aggregation
- Transmission across Chemical Synapses
- G alpha (q) signalling events
- Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
- Signal amplification
- Potassium Channels
- Activation of the phototransduction cascade
- Inactivation, recovery and regulation of the phototransduction cascade
- G beta:gamma signalling through PI3Kgamma
- The phototransduction cascade
- G alpha (12/13) signalling events
- Class B/2 (Secretin family receptors)
- Prostacyclin signalling through prostacyclin receptor
- GABA B receptor activation
- GABA receptor activation
- Activation of G protein gated Potassium channels
- Vasopressin regulates renal water homeostasis via Aquaporins
- Regulation of insulin secretion
- GPCR ligand binding
- beta-catenin independent WNT signaling
- Thrombin signalling through proteinase activated receptors (PARs)
- Presynaptic function of Kainate receptors
- Visual phototransduction
- Ca2+ pathway
- G-protein activation
|
|
|
|
|
|
GNB1 and HDAC4 |
guanine nucleotide binding protein (G protein), beta polypeptide 1 |
histone deacetylase 4 |
- Signaling by GPCR
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- ADP signalling through P2Y purinoceptor 1
- Integration of energy metabolism
- G alpha (s) signalling events
- Activation of GABAB receptors
- Glucagon-type ligand receptors
- G beta:gamma signalling through PLC beta
- Signaling by Wnt
- Metabolic disorders of biological oxidation enzymes
- G protein gated Potassium channels
- Olfactory Signaling Pathway
- Gastrin-CREB signalling pathway via PKC and MAPK
- Thromboxane signalling through TP receptor
- G alpha (z) signalling events
- G alpha (i) signalling events
- Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
- ADP signalling through P2Y purinoceptor 12
- Glucagon signaling in metabolic regulation
- Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits
- Inwardly rectifying K+ channels
- G-protein beta:gamma signalling
- Opioid Signalling
- Activation of Kainate Receptors upon glutamate binding
- Diseases associated with visual transduction
- Aquaporin-mediated transport
- Adrenaline,noradrenaline inhibits insulin secretion
- G alpha (q) signalling events
- GPCR downstream signaling
- Platelet homeostasis
- Platelet activation, signaling and aggregation
- Transmission across Chemical Synapses
- G alpha (q) signalling events
- Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
- Signal amplification
- Potassium Channels
- Activation of the phototransduction cascade
- Inactivation, recovery and regulation of the phototransduction cascade
- G beta:gamma signalling through PI3Kgamma
- The phototransduction cascade
- G alpha (12/13) signalling events
- Class B/2 (Secretin family receptors)
- Prostacyclin signalling through prostacyclin receptor
- GABA B receptor activation
- GABA receptor activation
- Activation of G protein gated Potassium channels
- Vasopressin regulates renal water homeostasis via Aquaporins
- Regulation of insulin secretion
- GPCR ligand binding
- beta-catenin independent WNT signaling
- Thrombin signalling through proteinase activated receptors (PARs)
- Presynaptic function of Kainate receptors
- Visual phototransduction
- Ca2+ pathway
- G-protein activation
|
- Signaling by NOTCH1 HD Domain Mutants in Cancer
- Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
- Signaling by NOTCH
- Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
- NOTCH1 Intracellular Domain Regulates Transcription
- Signaling by NOTCH1
- Signaling by NOTCH1 PEST Domain Mutants in Cancer
- Signaling by NOTCH1 in Cancer
- Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
- Constitutive Signaling by NOTCH1 PEST Domain Mutants
- FBXW7 Mutants and NOTCH1 in Cancer
|
|
|
|
|
GNG10 and TCF4 |
guanine nucleotide binding protein (G protein), gamma 10 |
transcription factor 4 |
- Signaling by GPCR
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- ADP signalling through P2Y purinoceptor 1
- Integration of energy metabolism
- G alpha (s) signalling events
- Activation of GABAB receptors
- Glucagon-type ligand receptors
- G beta:gamma signalling through PLC beta
- Signaling by Wnt
- Metabolic disorders of biological oxidation enzymes
- G protein gated Potassium channels
- Gastrin-CREB signalling pathway via PKC and MAPK
- Thromboxane signalling through TP receptor
- G alpha (z) signalling events
- G alpha (i) signalling events
- Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
- ADP signalling through P2Y purinoceptor 12
- Glucagon signaling in metabolic regulation
- Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits
- Inwardly rectifying K+ channels
- G-protein beta:gamma signalling
- Opioid Signalling
- Activation of Kainate Receptors upon glutamate binding
- Aquaporin-mediated transport
- Adrenaline,noradrenaline inhibits insulin secretion
- G alpha (q) signalling events
- GPCR downstream signaling
- Platelet homeostasis
- Platelet activation, signaling and aggregation
- Transmission across Chemical Synapses
- G alpha (q) signalling events
- Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
- Signal amplification
- Potassium Channels
- G beta:gamma signalling through PI3Kgamma
- G alpha (12/13) signalling events
- Class B/2 (Secretin family receptors)
- Prostacyclin signalling through prostacyclin receptor
- GABA B receptor activation
- GABA receptor activation
- Activation of G protein gated Potassium channels
- Vasopressin regulates renal water homeostasis via Aquaporins
- Regulation of insulin secretion
- GPCR ligand binding
- beta-catenin independent WNT signaling
- Thrombin signalling through proteinase activated receptors (PARs)
- Presynaptic function of Kainate receptors
- Ca2+ pathway
- G-protein activation
|
- CDO in myogenesis
- Myogenesis
|
|
|
|
|
GOLGA2 and HDAC4 |
golgin A2 |
histone deacetylase 4 |
- Mitotic Prophase
- Golgi Cisternae Pericentriolar Stack Reorganization
- Cell Cycle, Mitotic
- M Phase
|
- Signaling by NOTCH1 HD Domain Mutants in Cancer
- Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
- Signaling by NOTCH
- Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
- NOTCH1 Intracellular Domain Regulates Transcription
- Signaling by NOTCH1
- Signaling by NOTCH1 PEST Domain Mutants in Cancer
- Signaling by NOTCH1 in Cancer
- Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
- Constitutive Signaling by NOTCH1 PEST Domain Mutants
- FBXW7 Mutants and NOTCH1 in Cancer
|
|
|
|
|
GOLGA4 and TNIK |
golgin A4 |
TRAF2 and NCK interacting kinase |
|
- Oxidative Stress Induced Senescence
- Cellular Senescence
|
|
|
|
|
GPC1 and SLIT2 |
glypican 1 |
slit homolog 2 (Drosophila) |
- MPS IIIB - Sanfilippo syndrome B
- Diseases of glycosylation
- Defective B4GALT7 causes EDS, progeroid type
- Axon guidance
- Heparan sulfate/heparin (HS-GAG) metabolism
- MPS I - Hurler syndrome
- MPS IX - Natowicz syndrome
- Chondroitin sulfate/dermatan sulfate metabolism
- Defective SLC26A2 causes chondrodysplasias
- Glycosaminoglycan metabolism
- Inactivation of Cdc42 and Rac
- Defective CHST14 causes EDS, musculocontractural type
- Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
- Defective PAPSS2 causes SEMD-PA
- Activation of Rac
- MPS IIIA - Sanfilippo syndrome A
- Myoclonic epilepsy of Lafora
- Defective CHST6 causes MCDC1
- Glycogen storage diseases
- MPS IIID - Sanfilippo syndrome D
- A tetrasaccharide linker sequence is required for GAG synthesis
- MPS IIIC - Sanfilippo syndrome C
- Retinoid metabolism and transport
- Role of Abl in Robo-Slit signaling
- Diseases associated with glycosaminoglycan metabolism
- Mucopolysaccharidoses
- Defective EXT2 causes exostoses 2
- MPS II - Hunter syndrome
- Defective B3GAT3 causes JDSSDHD
- Defective CHST3 causes SEDCJD
- Defective EXT1 causes exostoses 1, TRPS2 and CHDS
- Diseases associated with visual transduction
- MPS IV - Morquio syndrome A
- Visual phototransduction
- MPS IV - Morquio syndrome B
- Defective CHSY1 causes TPBS
- MPS VII - Sly syndrome
- Metabolism of carbohydrates
- Signaling by Robo receptor
- HS-GAG biosynthesis
- HS-GAG degradation
- MPS VI - Maroteaux-Lamy syndrome
|
- Inactivation of Cdc42 and Rac
- Role of Abl in Robo-Slit signaling
- Axon guidance
- Activation of Rac
- Regulation of Commissural axon pathfinding by Slit and Robo
- Netrin-1 signaling
- Signaling by Robo receptor
|
|
|
|
|
GPC1 and COL18A1 |
glypican 1 |
collagen, type XVIII, alpha 1 |
- MPS IIIB - Sanfilippo syndrome B
- Diseases of glycosylation
- Defective B4GALT7 causes EDS, progeroid type
- Axon guidance
- Heparan sulfate/heparin (HS-GAG) metabolism
- MPS I - Hurler syndrome
- MPS IX - Natowicz syndrome
- Chondroitin sulfate/dermatan sulfate metabolism
- Defective SLC26A2 causes chondrodysplasias
- Glycosaminoglycan metabolism
- Inactivation of Cdc42 and Rac
- Defective CHST14 causes EDS, musculocontractural type
- Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
- Defective PAPSS2 causes SEMD-PA
- Activation of Rac
- MPS IIIA - Sanfilippo syndrome A
- Myoclonic epilepsy of Lafora
- Defective CHST6 causes MCDC1
- Glycogen storage diseases
- MPS IIID - Sanfilippo syndrome D
- A tetrasaccharide linker sequence is required for GAG synthesis
- MPS IIIC - Sanfilippo syndrome C
- Retinoid metabolism and transport
- Role of Abl in Robo-Slit signaling
- Diseases associated with glycosaminoglycan metabolism
- Mucopolysaccharidoses
- Defective EXT2 causes exostoses 2
- MPS II - Hunter syndrome
- Defective B3GAT3 causes JDSSDHD
- Defective CHST3 causes SEDCJD
- Defective EXT1 causes exostoses 1, TRPS2 and CHDS
- Diseases associated with visual transduction
- MPS IV - Morquio syndrome A
- Visual phototransduction
- MPS IV - Morquio syndrome B
- Defective CHSY1 causes TPBS
- MPS VII - Sly syndrome
- Metabolism of carbohydrates
- Signaling by Robo receptor
- HS-GAG biosynthesis
- HS-GAG degradation
- MPS VI - Maroteaux-Lamy syndrome
|
- Collagen formation
- Laminin interactions
- Collagen degradation
- Activation of Matrix Metalloproteinases
- Integrin cell surface interactions
- Collagen biosynthesis and modifying enzymes
- Degradation of the extracellular matrix
- Assembly of collagen fibrils and other multimeric structures
|
|
|
|
|
GPC1 and SLIT1 |
glypican 1 |
slit homolog 1 (Drosophila) |
- MPS IIIB - Sanfilippo syndrome B
- Diseases of glycosylation
- Defective B4GALT7 causes EDS, progeroid type
- Axon guidance
- Heparan sulfate/heparin (HS-GAG) metabolism
- MPS I - Hurler syndrome
- MPS IX - Natowicz syndrome
- Chondroitin sulfate/dermatan sulfate metabolism
- Defective SLC26A2 causes chondrodysplasias
- Glycosaminoglycan metabolism
- Inactivation of Cdc42 and Rac
- Defective CHST14 causes EDS, musculocontractural type
- Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
- Defective PAPSS2 causes SEMD-PA
- Activation of Rac
- MPS IIIA - Sanfilippo syndrome A
- Myoclonic epilepsy of Lafora
- Defective CHST6 causes MCDC1
- Glycogen storage diseases
- MPS IIID - Sanfilippo syndrome D
- A tetrasaccharide linker sequence is required for GAG synthesis
- MPS IIIC - Sanfilippo syndrome C
- Retinoid metabolism and transport
- Role of Abl in Robo-Slit signaling
- Diseases associated with glycosaminoglycan metabolism
- Mucopolysaccharidoses
- Defective EXT2 causes exostoses 2
- MPS II - Hunter syndrome
- Defective B3GAT3 causes JDSSDHD
- Defective CHST3 causes SEDCJD
- Defective EXT1 causes exostoses 1, TRPS2 and CHDS
- Diseases associated with visual transduction
- MPS IV - Morquio syndrome A
- Visual phototransduction
- MPS IV - Morquio syndrome B
- Defective CHSY1 causes TPBS
- MPS VII - Sly syndrome
- Metabolism of carbohydrates
- Signaling by Robo receptor
- HS-GAG biosynthesis
- HS-GAG degradation
- MPS VI - Maroteaux-Lamy syndrome
|
- Axon guidance
- Netrin-1 signaling
|
|
|
|
|
GPC1 and VEGFA |
glypican 1 |
vascular endothelial growth factor A |
- MPS IIIB - Sanfilippo syndrome B
- Diseases of glycosylation
- Defective B4GALT7 causes EDS, progeroid type
- Axon guidance
- Heparan sulfate/heparin (HS-GAG) metabolism
- MPS I - Hurler syndrome
- MPS IX - Natowicz syndrome
- Chondroitin sulfate/dermatan sulfate metabolism
- Defective SLC26A2 causes chondrodysplasias
- Glycosaminoglycan metabolism
- Inactivation of Cdc42 and Rac
- Defective CHST14 causes EDS, musculocontractural type
- Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
- Defective PAPSS2 causes SEMD-PA
- Activation of Rac
- MPS IIIA - Sanfilippo syndrome A
- Myoclonic epilepsy of Lafora
- Defective CHST6 causes MCDC1
- Glycogen storage diseases
- MPS IIID - Sanfilippo syndrome D
- A tetrasaccharide linker sequence is required for GAG synthesis
- MPS IIIC - Sanfilippo syndrome C
- Retinoid metabolism and transport
- Role of Abl in Robo-Slit signaling
- Diseases associated with glycosaminoglycan metabolism
- Mucopolysaccharidoses
- Defective EXT2 causes exostoses 2
- MPS II - Hunter syndrome
- Defective B3GAT3 causes JDSSDHD
- Defective CHST3 causes SEDCJD
- Defective EXT1 causes exostoses 1, TRPS2 and CHDS
- Diseases associated with visual transduction
- MPS IV - Morquio syndrome A
- Visual phototransduction
- MPS IV - Morquio syndrome B
- Defective CHSY1 causes TPBS
- MPS VII - Sly syndrome
- Metabolism of carbohydrates
- Signaling by Robo receptor
- HS-GAG biosynthesis
- HS-GAG degradation
- MPS VI - Maroteaux-Lamy syndrome
|
- VEGF binds to VEGFR leading to receptor dimerization
- Cellular response to hypoxia
- VEGF ligand-receptor interactions
- Regulation of Hypoxia-inducible Factor (HIF) by oxygen
- Signaling by VEGF
- Response to elevated platelet cytosolic Ca2+
- Platelet degranulation
- Platelet activation, signaling and aggregation
- Regulation of gene expression by Hypoxia-inducible Factor
|
|
- Bevacizumab
- Minocycline
- Gliclazide
- Carvedilol
- Ranibizumab
- Pyroglutamic Acid
- Tris(Hydroxymethyl)Aminomethane
- Vandetanib
- Dalteparin
- Aflibercept
|
|
|
GPR1 and TPST1 |
G protein-coupled receptor 1 |
tyrosylprotein sulfotransferase 1 |
|
|
|
|
|
|
GPR1 and TPST2 |
G protein-coupled receptor 1 |
tyrosylprotein sulfotransferase 2 |
|
|
|
|
|
|
CCR10 and PRRC2A |
chemokine (C-C motif) receptor 10 |
proline-rich coiled-coil 2A |
- Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
- Signaling by GPCR
- GPCR downstream signaling
- Peptide ligand-binding receptors
- Chemokine receptors bind chemokines
- Class A/1 (Rhodopsin-like receptors)
- G alpha (i) signalling events
- Metabolic disorders of biological oxidation enzymes
- GPCR ligand binding
|
|
|
|
|
|
GRB2 and ITIH4 |
growth factor receptor-bound protein 2 |
inter-alpha-trypsin inhibitor heavy chain family, member 4 |
|
|
- Pegademase bovine
- 4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid
|
|
|
|
GRB2 and PRRC2A |
growth factor receptor-bound protein 2 |
proline-rich coiled-coil 2A |
|
|
- Pegademase bovine
- 4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid
|
|
|
|